Ziabitos capsule effect on blood glucose control

Diabetes Explanation & Evaluation the Effect of Ziabitos capsule consumption on Blood Glucose Control, in Patients with Type 2 Diabetes, in Traditional Iranian medicine.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201108107286N1

Enrollment

Registered

2011-11-06

Start date

2011-10-12

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabet. Diabetes Mellitus

Interventions

Ziabitos, 500 mg oral capsule, three times daily, for four weeks.

Treatment - Drugs

Ziabitos, 500 mg oral capsule, three times daily, for four weeks

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- Age: 30 – 70 years 2- Uncontrolled Type 2 Diabetes: (HbA1c >7%) 3- Treated with oral diabetes medications (one or more Pharmaceutical group) 4- Over at least a month, since the addition of anti-diabetic drug dosage or prescribe a new anti-diabetic drug ?Exclusion criteria: 1- GFR (Glomerular Filtration Rate) < 60 ml/mi 2- Serum Alb < 4 gr/dl 3 - High SGOT and SGPT: more than three times the normal

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
2h postparandial blood suger. Timepoint: Before and four weeks after Intervention. Method of measurement: Mg per deciliter and a lab kit.;Serum Fructosamine. Timepoint: Before and four weeks after Intervention. Method of measurement: Micromol per liter and a lab kit.;Fasting Blood Sugar. Timepoint: Before and four weeks after Intervention. Method of measurement: Mg per deciliter and a lab kit.	—

Secondary

Measure	Time frame
Triglycerid. Timepoint: Before and four weeks after Intervention. Method of measurement: Mg per deciliter and a lab kit.;Total cholestrol. Timepoint: Before and four weeks after Intervention. Method of measurement: Mg per deciliter and a lab kit.;Aspartat Aminotransferase. Timepoint: Before and four weeks after Intervention. Method of measurement: unit per liter and a lab kit.;Blood Urea Nitrogen. Timepoint: Before and four weeks after Intervention. Method of measurement: Meq per liter and a lab kit.;Cratinin. Timepoint: Before and four weeks after Intervention. Method of measurement: Meq per liter and a lab kit.;Alanin Aminotransferase. Timepoint: Before and four weeks after Intervention. Method of measurement: unit per liter and a lab kit.;Sodium (Na). Timepoint: Before and four weeks after Intervention. Method of measurement: Meq per liter and a lab kit.;Potasium(K). Timepoint: Before and four weeks after Intervention. Method of measurement: Meq per liter and a lab kit.;Serum Albumin. Timepoint: Before and four weeks after Intervention. Method of measurement: gr per deciliter and a lab kit.;Glumerolar Filteration Rate (GFR). Timepoint: Before and four weeks after Intervention. Method of measurement: Ml Per Min And Glomerular filtration rate calculated using the formula.;Complit Blood Count (CBC). Timepoint: Before and four weeks after Intervention. Method of measurement: Based on the number And Lab kit.;Hemoglobin A1c Glycosilate (HbA1c). Timepoint: Before of Intervention(in beginning of study). Method of measurement: per cent and a lab kit.	—

Measure

Time frame

Triglycerid. Timepoint: Before and four weeks after Intervention. Method of measurement: Mg per deciliter and a lab kit.;Total cholestrol. Timepoint: Before and four weeks after Intervention. Method of measurement: Mg per deciliter and a lab kit.;Aspartat Aminotransferase. Timepoint: Before and four weeks after Intervention. Method of measurement: unit per liter and a lab kit.;Blood Urea Nitrogen. Timepoint: Before and four weeks after Intervention. Method of measurement: Meq per liter and a lab kit.;Cratinin. Timepoint: Before and four weeks after Intervention. Method of measurement: Meq per liter and a lab kit.;Alanin Aminotransferase. Timepoint: Before and four weeks after Intervention. Method of measurement: unit per liter and a lab kit.;Sodium (Na). Timepoint: Before and four weeks after Intervention. Method of measurement: Meq per liter and a lab kit.;Potasium(K). Timepoint: Before and four weeks after Intervention. Method of measurement: Meq per liter and a lab kit.;Serum Albumin. Timepoint: Before and four weeks after Intervention. Method of measurement: gr per deciliter and a lab kit.;Glumerolar Filteration Rate (GFR). Timepoint: Before and four weeks after Intervention. Method of measurement: Ml Per Min And Glomerular filtration rate calculated using the formula.;Complit Blood Count (CBC). Timepoint: Before and four weeks after Intervention. Method of measurement: Based on the number And Lab kit.;Hemoglobin A1c Glycosilate (HbA1c). Timepoint: Before of Intervention(in beginning of study). Method of measurement: per cent and a lab kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Asghari

Shahed University

Asghari@Razi.Tums.ac.ir Asghari@Shahed.ac.ir+98 21 8895 4412

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026